NasdaqGS - Nasdaq Real Time Price USD
Bio-Techne Corporation (TECH)
50.71
+0.55
+(1.09%)
As of 1:31:23 PM EDT. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
304,717
298,981
254,393
325,272
352,164
Investing Cash Flow
-51,965
-203,030
-265,649
-96,851
-243,516
Financing Cash Flow
-207,919
-122,398
22,616
-242,853
-62,551
End Cash Position
174,965
151,791
180,571
172,567
199,091
Income Tax Paid Supplemental Data
66,499
65,254
88,428
30,341
20,952
Interest Paid Supplemental Data
14,450
14,502
8,368
11,027
13,576
Capital Expenditure
-50,414
-62,877
-38,244
-44,908
-44,301
Issuance of Debt
--
225,000
619,661
90,000
256,000
Repayment of Debt
-147,000
-256,000
-525,661
-175,500
-271,500
Repurchase of Capital Stock
-75,628
-80,042
-19,562
-160,950
-43,178
Free Cash Flow
254,303
236,104
216,149
280,364
307,863
6/30/2021 - 2/9/1989
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NUVL Nuvalent, Inc.
72.19
-0.72%
GMAB Genmab A/S
20.47
+1.66%
BMRN BioMarin Pharmaceutical Inc.
62.60
+1.07%
INCY Incyte Corporation
58.40
+0.69%
PCVX Vaxcyte, Inc.
33.75
+1.76%
ROIV Roivant Sciences Ltd.
10.90
+1.44%
RPRX Royalty Pharma plc
31.95
+0.82%
JAZZ Jazz Pharmaceuticals plc
107.96
+3.62%
IMVT Immunovant, Inc.
14.76
+2.15%
ASND Ascendis Pharma A/S
155.93
-1.40%